跳至主要内容
临床试验/NCT03594708
NCT03594708Unknown不适用

Impact of Immunonutrition Supplementation Combining Fermentable Fiber, Omega-3 Fatty Acids, Vitamin D, Vitamin E, and Zinc on Intestinal Inflammation, Gut Microbial Activity, and Severity of Symptoms in Ulcerative Colitis Patients

Baptist Memorial Health Care Corporation2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年4月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
试验地点
2
主要终点
Reduced inflammatory cytokines

研究概览

简要总结

This study tests the hypothesis that a supplement that combines a functional fiber, long chain omega-3 polyunsaturated fatty acids (PUFAs), vitamin D3, vitamin E, and zinc will reduce clinical symptoms, decrease pro-inflammatory cytokines in the blood and ergo decrease inflammation, promote beneficial microbial activity in the colon, and help recovery of the intestinal mucosa of ulcerative colitis (UC) patients compared with a placebo.

详细描述

An anticipated 30 participants with newly diagnosed active ulcerative colitis will be recruited to participate in a randomized control trial, with 50% of the subjects distributed to the supplement (n=15) and the other 50% provided a placebo control (n=15). This is considered as a "proof of concept" study to determine if there is evidence that a multi-ingredient supplement (immunonutrition) will reduce UC disease severity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with active ulcerative colitis (proof of diagnosis from gastroenterologist), over 18 years old, has over 50% gut remaining, fully connected bowels (no colostomy), currently on 5-aminosalicylates (ASA) drugs, not pregnant or lactating

排除标准

  • 未提供

研究组 & 干预措施

Supplement

Active Comparator

active supplement consisting of a fermentable fiber, omega-3 polyunsaturated fatty acid, vitamin D3, vitamin E, and zinc

干预措施: Nutrition supplement (Dietary Supplement)

Placebo

Placebo Comparator

placebo consisting of rice starch, light olive oil, and vegetable oil

干预措施: Placebo supplement (Dietary Supplement)

结局指标

主要结局

Reduced inflammatory cytokines

时间窗: 2 months

cytokines will be isolated from blood analysis

次要结局

  • Improved microbiome/ increased Short-Chain Fatty acid (SCFA) counts(2 months)
  • Reduced bowel movements per day(2 months)
  • Decreased intestinal cramping/ pain(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katherine Cook

Research Assistant

Baptist Memorial Health Care Corporation

研究点 (2)

Loading locations...

相似试验